Xiao-juan L. Yu

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID.

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID -Dexamethasone versus Rituximab in PGNMID.

Clarifying the immunoglobulin light chain variable gene usage in Chinese patients with renal AL amyloidosis.

Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease.

Showing 1-12 of 76

Last Updated: 09/26/2026